SANUWAVE Health (SNWV) Cash from Financing Activities (2010 - 2026)
SANUWAVE Health's (SNWV) quarterly Cash from Financing Activities came in at -$1.4 million in Q1 2026, down 2389.47% year-on-year from $61979.3 in Q1 2025, and down 14.34% on a QoQ basis from -$1.2 million in Q4 2025.
SANUWAVE Health (SNWV) Cash from Financing Activities (2010 - 2026) Analysis & Trends
SANUWAVE Health (SNWV) has 16 years of Cash from Financing Activities data on file, last reported at -$1.4 million in Q1 2026.
- On a quarterly basis, Cash from Financing Activities fell 2389.47% year-over-year to -$1.4 million in Q1 2026; TTM through Mar 2026 was -$6.9 million, a 211.1% decrease from a year earlier, with the FY2025 full-year figure at -$5.6 million, down 187.93% from the prior year.
- Cash from Financing Activities for Q1 2026 stood at -$1.4 million, down from -$1.2 million in the prior quarter.
- Over the last five years, Cash from Financing Activities for SNWV reached as high as $7.6 million in Q3 2022 and fell as low as -$4.4 million in Q3 2025.
- Historically, Cash from Financing Activities has averaged $1.3 million across 5 years, with a median of $274000.0 in 2024.
- Across the five-year window, Cash from Financing Activities jumped 1943.29% in 2022 and slumped 2389.47% in 2026, its largest moves.
- Year by year, Cash from Financing Activities stood at $4.7 million in 2022, then plunged by 60.7% to $1.9 million in 2023, then jumped by 248.95% to $6.5 million in 2024, then sank by 119.17% to -$1.2 million in 2025, then dropped by 14.34% to -$1.4 million in 2026.
- Per Business Quant data, the three most recent Cash from Financing Activities figures were -$1.4 million in Q1 2026, -$1.2 million in Q4 2025, and -$4.4 million in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Cash from Financing Activities (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 201.40 Bn | 194.75 Bn | 6.27 Bn | 17.31 Bn |
| 2 | Stryker | 122.29 Bn | 119.41 Bn | 3.81 Bn | -1.51 Bn |
| 3 | Medtronic | 105.01 Bn | 96.40 Bn | 6.41 Bn | -888.00 Mn |
| 4 | Boston Scientific | 64.81 Bn | 63.59 Bn | 3.61 Bn | -260.00 Mn |
| 5 | Edwards Lifesciences | 55.28 Bn | 51.60 Bn | 1.29 Bn | -451.20 Mn |
| 6 | Dexcom | 29.06 Bn | 27.94 Bn | 750.30 Mn | -25.00 Mn |
| 7 | Koninklijke Philips | 29.02 Bn | 25.93 Bn | 2.07 Bn | -26.93 Mn |
| 8 | GE HealthCare Technologies | 28.27 Bn | 26.20 Bn | 1.98 Bn | 21.00 Mn |
| 9 | Smith & Nephew | 25.80 Bn | 25.22 Bn | - | - |
| 10 | SANUWAVE Health | 18.65 Mn | 7.87 Mn | 7.43 Mn | -1.42 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -1.42 Mn |
| Mar 31, 2026 | -1.42 Mn |
| Dec 31, 2025 | -1.24 Mn |
| Dec 31, 2025 | -1.24 Mn |
| Sep 30, 2025 | -4.45 Mn |
| Sep 30, 2025 | -4.45 Mn |
| Jun 30, 2025 | 161,000.00 |
| Jun 30, 2025 | 161,000.00 |
| Mar 31, 2025 | -57,000.00 |
| Mar 31, 2025 | -57,000.00 |
| Dec 31, 2024 | 6.47 Mn |
| Dec 31, 2024 | 6.47 Mn |
| Sep 30, 2024 | -435,000.00 |
| Sep 30, 2024 | -435,000.00 |
| Jun 30, 2024 | 274,000.00 |
| Jun 30, 2024 | 274,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Mar 31, 2024 | 42,000.00 |
| Dec 31, 2023 | 1.86 Mn |
| Dec 31, 2023 | 1.86 Mn |